---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-029711"
form_type: "8-K"
ticker: "IMNN"
cik: "0000749647"
company_name: "Imunon, Inc."
filed_at: "2025-12-31T23:59:59+00:00"
generated_at: "2026-05-16T11:56:50.068318+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Imunon raises $7.0M in registered direct offering of common stock and warrants

## Summary
- Gross proceeds ~$7.0M from 1,939,114 shares/pre-funded warrants plus warrants at $3.61/unit.
- Warrants exercisable at $3.482/share for 5 years; pre-funded warrants at $0.0001, no expiration.
- Offering priced at-the-market under Nasdaq rules; expected to close December 31, 2025.
- Net proceeds for general corporate purposes including R&D, capex, and working capital.
- Maxim Group LLC is lead placement agent; Brookline Capital Markets is co-placement agent.

## SEC filing metadata
- accession: 0001493152-25-029711
- form_type: 8-K
- ticker: IMNN
- cik: 0000749647
- company_name: Imunon, Inc.
- filed_at: 2025-12-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/749647/000149315225029711/0001493152-25-029711-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/749647/000149315225029711/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-029711
- JSON: https://secwatch.observer/filing/0001493152-25-029711.json
- Plain text: https://secwatch.observer/filing/0001493152-25-029711.txt

## Key facts
- Material Agreements
  Imunon, Inc. entered into Securities Purchase Agreement with a single healthcare-focused institutional investor valued at combined offering price of $3.61 per Share and Warrant (effective 2025-12-29).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: a single healthcare-focused institutional investor
  - Value: combined offering price of $3.61 per Share and Warrant
  - Effective: 2025-12-29
  source text: On December 29, 2025, Imunon, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single healthcare-focused institutional investor (the “Purchaser”) for a registered direct offering
  evidence_url: https://www.sec.gov/Archives/edgar/data/749647/000149315225029711/0001493152-25-029711-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.